1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NIH Small Business Innovation Research (SBIR) Program is a grant from NIH NIDA that funds small businesses developing innovative technologies and products related to drug abuse and addiction. NIDA awards more than $50 million annually through its SBIR and STTR programs, with individual project awards of up to $3. 4 million.
Grantees retain full equity in their work. The program supports entrepreneurs, startups, and established small businesses pursuing biomarker discovery, pharmacotherapeutic development, and medical device innovation in the substance use disorder space. Eligible applicants are U.S.-based small businesses; applicants are encouraged to discuss proposals with NIDA program staff before applying.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Small Business Innovation Research (SBIR) and Technology Transfer (STTR) Programs | National Institute on Drug Abuse (NIDA) Small Business Innovation Research (SBIR) and Technology Transfer (STTR) Programs Each year, NIDA provides more than $50 million in awards to small businesses through the Small Business programs. That’s up to $3. 4 million in funding per project and all equity remains with grantees.
NIDA invites aspiring entrepreneurs, startups, and small businesses to explore this section and begin the application process.
View the Landscape of Pharmacotherapeutic Development View the Landscape of Medical Device Development Get Started with the Application Process Access a suite of resources to successfully submit a grant application Additional resources for companies Review a complete collection of small business grants previously awarded by NIDA Access current small business opportunities from NIDA SBIR/STTR Success Stories The following companies have received NIDA funding through the SBIR and STTR programs Target Product Profiles (TPPs) for Medical Product Development Before applying, potential applicants are strongly encouraged to discuss their research proposals
According to the current listing, eligibility includes: Small businesses in the United States. Confirm the full requirements in the official notice before applying.
The current listing shows $150,000 - $1,500,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
NIH Small Business Innovation Research (SBIR) Program is funded by NIH NIDA. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article